STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
What the filings say about SAR
Insiders, 180 days
+$445.8K net bought
1 buyer
Saratoga Investment insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, SARATOGA INVESTMENT CORP. insiders bought a net $445.8K of stock across 4 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on May 4, 2023.
The trade is 100.0% of the 15,000 shares held after it.
No other insider bought within 30 days.
Insider activity: CEO and Director Oberbeck Christian L bought about $223.3K of SAR on Oct 8, 2026, the largest insider purchase at the company on our record.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 0.3% of the 689,775 shares held after it.
No other insider bought within 30 days.
Insider activity: CEO, Director and President Oberbeck Christian L bought about $47.6K of SAR on May 4, 2023, the largest insider purchase at the company on our record.
TTM operating cash flow over long-term debt only, 2026-08-31
Cash flow to debt SAR
FY Feb 2026
-0.12x
FY Feb 2025
0.25x
FY Feb 2024
-191.63x
FY Feb 2023
-0.18x
FY Feb 2022
n/a
Aug 2026
-0.17x
May 2026
-0.18x
Feb 2026
-0.12x
Nov 2025
-0.02x
Aug 2025
0.11x
May 2025
0.22x
Feb 2025
0.25x
Nov 2024
0.23x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-1.1%
TTM net income over average of 2025-08-31 and 2026-08-31
Return on equity SAR
FY Feb 2026
+9.3%
FY Feb 2025
+7.4%
FY Feb 2024
+2.5%
FY Feb 2023
+7.0%
FY Feb 2022
n/a
Aug 2026
-1.1%
May 2026
+4.1%
Feb 2026
+9.3%
Nov 2025
+9.8%
Aug 2025
+9.0%
May 2025
+9.3%
Feb 2025
+7.4%
Nov 2024
+9.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-0.3%
TTM net income over average of 2025-08-31 and 2026-08-31
Return on assets SAR
FY Feb 2026
+3.1%
FY Feb 2025
+2.4%
FY Feb 2024
+0.8%
FY Feb 2023
+2.5%
FY Feb 2022
n/a
Aug 2026
-0.3%
May 2026
+1.3%
Feb 2026
+3.1%
Nov 2025
+3.2%
Aug 2025
+2.9%
May 2025
+2.9%
Feb 2025
+2.4%
Nov 2024
+2.8%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital SAR
FY Feb 2026
n/a
FY Feb 2025
n/a
FY Feb 2024
n/a
FY Feb 2023
n/a
FY Feb 2022
n/a
Aug 2026
n/a
May 2026
n/a
Feb 2026
n/a
Nov 2025
n/a
Aug 2025
n/a
May 2025
n/a
Feb 2025
n/a
Nov 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed SAR
FY Feb 2026
n/a
FY Feb 2025
n/a
FY Feb 2024
n/a
FY Feb 2023
n/a
FY Feb 2022
n/a
Aug 2026
n/a
May 2026
n/a
Feb 2026
n/a
Nov 2025
n/a
Aug 2025
n/a
May 2025
n/a
Feb 2025
n/a
Nov 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
P/E, trailing SAR
FY Feb 2026
10.03x
FY Feb 2025
12.87x
FY Feb 2024
31.91x
FY Feb 2023
13.31x
FY Feb 2022
n/a
Aug 2026
n/a
May 2026
22.97x
Feb 2026
10.03x
Nov 2025
9.60x
Aug 2025
11.01x
May 2025
10.11x
Feb 2025
12.87x
Nov 2024
10.24x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$1.0B
market value at close 2026-10-23 on 2026-10-05 shares, plus long-term debt only, 2026-08-31, minus cash 2026-08-31
Enterprise value SAR
FY Feb 2026
$1.1B
FY Feb 2025
$1.0B
FY Feb 2024
$314.5M
FY Feb 2023
$990.2M
FY Feb 2022
n/a
Aug 2026
$1.1B
May 2026
$1.1B
Feb 2026
$1.1B
Nov 2025
$1.1B
Aug 2025
$1.1B
May 2025
$1.0B
Feb 2025
$1.0B
Nov 2024
$1.0B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
capex not filed for the four quarters
FCF yield SAR
FY Feb 2026
n/a
FY Feb 2025
n/a
FY Feb 2024
n/a
FY Feb 2023
n/a
FY Feb 2022
n/a
Aug 2026
n/a
May 2026
n/a
Feb 2026
n/a
Nov 2025
n/a
Aug 2025
n/a
May 2025
n/a
Feb 2025
n/a
Nov 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
PEG, trailing SAR
FY Feb 2026
0.70x
FY Feb 2025
0.07x
FY Feb 2024
n/a
FY Feb 2023
n/a
FY Feb 2022
n/a
Aug 2026
n/a
May 2026
n/a
Feb 2026
0.70x
Nov 2025
n/a
Aug 2025
0.23x
May 2025
0.10x
Feb 2025
0.07x
Nov 2024
0.33x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
SAR ranks highest on insider conviction (45th percentile) and risk and compliance (31st), and lowest on financial health (13th), among Funds & Trusts peers.
Profitability
22
Inputs
Return on equity-1.1% · 22 pct, sector of 37
Return on assets-0.3% · 22 pct, sector of 38
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Financial health
13
Inputs
Debt to equity2.56x · 9 pct, universe of 3,589
Cash flow to debt-0.17x · 17 pct, sector of 30
Insider conviction
45
Inputs
Net Form 4 buying (codes P and S), 180d$446K · 75 pct, sector of 142
Insider buyers, 180d1 · 14 pct, sector of 142
Risk and compliance
31
Inputs
Short interest, % of shares outstanding (no float on file)+4.0% · 31 pct, sector of 46
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
3 not measured: Growth, Institutional and government, US patents
Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
SAR filings, in plain words
Are Saratoga Investment insiders buying or selling SAR?
In the 180 days to 2026-10-27, Saratoga Investment insiders were net buyers, a net $445.8K across purchases and sales reported on Form 4, by 1 buyer.
Read the full summary
In the 180 days to 2026-10-27, Saratoga Investment insiders were net buyers of SAR, a net $445.8K across purchases and sales reported on Form 4 by 1 buyer. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.